Approach to the Patient With Pituitary Adenoma Using Telemedicine: Knowledge Gaps and Recommendations

Abstract

Telemedicine (TM) can be defined as the practice of medicine using technology such as video teleconferencing, telephone calls, or emails in order to provide health care from a distance. The emergence of the coronavirus disease 2019 (COVID-19) pandemic and its potential complications have created an urgent need for the transformation of physical visits into virtual encounters. Pituitary adenomas are one of the common endocrine tumors and can manifest with hormonal or mass effects. COVID-19 impacted the common pathway of diagnosis and treatment of these masses. TM utilization for pituitary adenomas has not been addressed thoroughly in the literature despite how common they are. In this review article, we discuss and implement what has been written in the literature about TM for pituitary adenoma alongside our suggested protocol.

J Endocrinol Metab. 2023;13(2):43-48
doi: https://doi.org/10.14740/jem866